Enveric Biosciences (ENVB) announced that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application pertaining to its EVM401 Series of molecules being developed as potential treatments for mental health disorders.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVB: